The mucosal immune system in the oral cavity-an orchestra of T cell diversity

International Journal of Oral Science

Volumn 6, Issue 3, 2014, Pages 125-132

  Wu, Rui Qing ^a,b   Zhang, Dun Fang ^a,b   Tu, Eric ^a   Chen, Qian Ming ^b   Chen, Wanjun ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

mucosal immune system; oral pharyngeal mucosa; T cell

Indexed keywords

CELLULAR IMMUNITY; CLASSIFICATION; EPITHELIUM; HUMAN; IMMUNOLOGY; MOUTH DISEASE; MOUTH MUCOSA; MUCOSAL IMMUNITY; PHARYNX; T LYMPHOCYTE SUBPOPULATION;

EPITHELIUM; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; MOUTH DISEASES; MOUTH MUCOSA; PHARYNX; T-LYMPHOCYTE SUBSETS;

EID: 84922017428     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2014.48     Document Type: Review

References (98)

1. Murphy KP. Janeway's immunobiology. 8th ed. London/New York: Garland Science, Taylor & Francis Group, 2011: 465-466.
2. van Wijk F, Cheroutre H. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin Immunol 2009; 21(3): 130-138.
3. Dobbins WO 3rd. Human intestinal intraepithelial lymphocytes. Gut 1986; 27(8): 972-985.
4. van Wijk F, Cheroutre H. Mucosal T cells in gut homeostasis and inflammation. Expert Rev Clin Immunol 2010; 6(4): 559-566.
5. Konkel JE, Chen W. Balancing acts: the role of TGF-b in the mucosal immune system. Trends Mol Med 2011; 17(11): 668-676.
6. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD41 T cells. Science 2010; 327(5969): 1098-1102.
7. Zhou L, Chong MM, Littman DR. Plasticity of CD41 T cell lineage differentiation. Immunity 2009; 30(5): 646-655.
8. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383(6603): 787-793.
9. Ma CS, Deenick EK, BattenMet al. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012; 209(7): 1241-1253.
10. Amsen D, Spilianakis CG, Flavell RA. How are TH1 and TH2 effector cells made? Curr Opin Immunol 2009; 21(2): 153-160.
11. Dong C, Flavell RA. Control of T helper cell differentiation-in search of master genes. Sci STKE 2000; 2000(49): pe1.
12. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3(2): 133-146.
13. Powrie F, LeachMW,Mauze S et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD41 T cells. Immunity 1994; 1(7): 553-562.
14. Tu E, Ang DK, Bellingham SA et al. Both IFN-c and IL-17 are required for the development of severe autoimmune gastritis. Eur J Immunol 2012; 42(10): 2574-2583.
15. Ouyang W, Ranganath SH, Weindel K et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998; 9(5): 745-755.
16. Anderson MK. Changing course by lymphocyte lineage redirection. Nat Immunol 2013; 14(3): 199-201.
17. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004; 25(11): 570-577.
18. Taylor MD, van der Werf N, Maizels RM. T cells in helminth infection: the regulators and the regulated. Trends Immunol 2012; 33(4): 181-189.
19. Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just TH2 cells. Nat Rev Immunol 2010; 10(12): 838-848.
20. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6(4): 329-333.
21. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8(5): 337-348.
22. Schambach F, Schupp M, Lazar MA et al. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007; 37(9): 2396-2399.
23. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8(4): 345-350.
24. Ghoreschi K, Laurence A, Yang XP et al. Generation of pathogenic TH17 cells in the absence of TGF-b signalling. Nature 2010; 467(7318): 967-971.
25. Maruyama T, Li J, Vaque JP et al. Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3. Nat Immunol 2011; 12(1): 86-95.
26. Locksley RM. Nine lives: plasticity among T helper cell subsets. J Exp Med 2009; 206(8): 1643-1646.
27. Veldhoen M, Uyttenhove C, van Snick J et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9(12): 1341-1346.
28. Schmitt E, Germann T, Goedert S et al. IL-9 production of naive CD41 T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 1994; 153(9): 3989-3996.
29. Chang HC, Sehra S, Goswami R et al. The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010; 11(6): 527-534.
30. Temann UA, Geba GP, Rankin JA et al. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998; 188(7): 1307-1320.
31. Duhen T, Geiger R, Jarrossay D et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10(8): 857-863.
32. Trifari S, Kaplan CD, Tran EH et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nat Immunol 2009; 10(8): 864-871.
33. Bird PI, Trapani JA, Villadangos JA. Endolysosomal proteases and their inhibitors in immunity. Nat Rev Immunol 2009; 9(12): 871-882.
34. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12(5): 383-390.
35. Basu R, O'Quinn DB, Silberger DJ et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012; 37(6): 1061-1075.
36. Boniface K, Bernard FX, Garcia M et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005; 174(6): 3695-3702.
37. Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008; 29(6): 947-957.
38. Ouyang W, Valdez P. IL-22 in mucosal immunity. Mucosal Immunol 2008; 1(5): 335-338.
39. Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev 2010; 21(6): 435-441.
40. Chen W. Tregs in immunotherapy: opportunities and challenges. Immunotherapy 2011; 3(8): 911-914.
41. Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD41CD252 naive T cells to CD41CD251 regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198(12): 1875-1886.
42. Chen W, Konkel JE. TGF-beta and 'adaptive' Foxp31 regulatory T cells. J Mol Cell Biol 2010; 2(1): 30-36.
43. Liu Y, Zhang P, Li J et al. A critical function for TGF-beta signaling in the development of natural CD41CD251Foxp31 regulatory T cells. Nat Immunol 2008; 9(6): 632-640.
44. Maruyama T, Konkel JE, Zamarron BF et al. The molecular mechanisms of Foxp3 gene regulation. Semin Immunol 2011; 23(6): 418-423.
45. Perruche S, Zhang P, Liu Y et al. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008; 14(5): 528-535.
46. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009; 30(5): 616-625.
47. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101(5): 455-458.
48. Chen W, Jin W, Wahl SM. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD41 T cells. J Exp Med 1998; 188(10): 1849-1857.
49. Wahl SM, Va zquez N, Chen W. Regulatory T cells and transcription factors: gatekeepers in allergic inflammation. Curr Opin Immunol 2004; 16(6): 768-774.
50. Carpenter AC, Bosselut R. Decision checkpoints in the thymus. Nat Immunol 2010; 11(8): 666-673.
51. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 2011; 11(7): 445-456.
52. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2(5): 336-345.
53. Ciofani M, Zuniga-Pflucker JC. Determining cd versus ab T cell development. Nat Rev Immunol 2010; 10(9): 657-663.
54. Vantourout P, Hayday A. Six-of-the-best: unique contributions of cd T cells to immunology. Nat Rev Immunol 2013; 13(2): 88-100.
55. Bonneville M, O'Brien RL, Born WK. cd T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10(7): 467-478.
56. Jameson J, Ugarte K, Chen N et al. A role for skin cd T cells in wound repair. Science 2002; 296(5568): 747-749.
57. Simpson SJ, Hollander GA, Mizoguchi E et al. Expression of pro-inflammatory cytokines by TCR ab1 and TCR cd1 T cells in an experimental model of colitis. Eur J Immunol 1997; 27(1): 17-25.
58. Kanazawa H, Ishiguro Y, Munakata A et al. Multiple accumulation of Vd21 cd T-cell clonotypes in intestinal mucosa from patients with Crohn's disease. Dig Dis Sci 2001; 46(2): 410-416.
59. Shires J, Theodoridis E, Hayday AC. Biological insights into TCRcd1 and TCRab1 intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 2001; 15(3): 419-434.
60. Cawthon AG, Lu H, Alexander-Miller MA. Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8ab versus CD8aa expression. J Immunol 2001; 167(5): 2577-2584.
61. Gangadharan D, Lambolez F, Attinger A et al. Identification of pre-and postselection TCRab1 intraepithelial lymphocyte precursors in the thymus. Immunity 2006; 25(4): 631-641.
62. Konkel JE, Maruyama T, Carpenter AC et al. Control of the development of CD8aa1 intestinal intraepithelial lymphocytes by TGF-b. Nat Immunol 2011; 12(4): 312-319.
63. Denning TL, Granger SW, Granger S et al. Mouse TCRab1CD8aa intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses. J Immunol 2007; 178(7): 4230-4239.
64. Walker DM. Oral mucosal immunology: an overview. Ann Acad Med Singap 2004; 33(4 Suppl): 27-30.
65. Novak N, Haberstok J, Bieber T et al. The immune privilege of the oral mucosa. Trends Mol Med 2008; 14(5): 191-198.
66. Lu FX, Jacobson RS. Oral mucosal immunity and HIV/SIV infection. J Dent Res 2007; 86(3): 216-226.
67. Kiyono H, Fukuyama S. NALT-versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004; 4(9): 699-710.
68. Zuercher AW, Coffin SE, Thurnheer MC et al. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J Immunol 2002; 168(4): 1796-1803.
69. Barrett AW, Cruchley AT, Williams DM. Oral mucosal Langerhans' cells. Crit Rev Oral Biol Med 1996; 7(1): 36-58.
70. Cutler CW, Jotwani R. Dendritic cells at the oral mucosal interface. J Dent Res 2006; 85(8): 678-689.
71. Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005; 7(2): 119-133.
72. Gomes Pde S, Fernandes MH. Defensins in the oral cavity: distribution and biological role. J Oral Pathol Med 2010; 39(1): 1-9.
73. Hovav AH. Dendritic cells of the oral mucosa. Mucosal Immunol 2014; 7(1): 27-37.
74. Patinen P, Savilahti E, Hietanen J et al. Intraepithelial lymphocytes bearing the c/d receptor in the oral and jejunal mucosa in patients with dermatitis herpetiformis. Eur J Oral Sci 1997; 105(2): 130-135.
75. Walton LJ, Macey MG, Thornhill MH et al. Intra-epithelial subpopulations of T lymphocytes and Langerhans cells in oral lichen planus. J Oral Pathol Med 1998; 27(3): 116-123.
76. Cohen MS, Shaw GM, McMichael AJ et al. Acute HIV-1 Infection. N Engl J Med 2011; 364(20): 1943-1954.
77. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11(4): 275-288.
78. Huang W, Na L, Fidel PL et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004; 190(3): 624-631.
79. Conti HR, Baker O, Freeman AF et al. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 2011; 4(4): 448-455.
80. Conti HR, Shen F, NayyarNet al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206(2): 299-311.
81. Cheng SC, van de Veerdonk F, Smeekens S et al. Candida albicans dampens host defense by downregulating IL-17 production. J Immunol 2010; 185(4): 2450-2457.
82. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008; 79(8 Suppl): 1569-1576.
83. Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 2002; 13(1): 17-34.
84. Wu RQ, Zhao XF, Wang ZY et al. Novel molecular events in oral carcinogenesis via integrative approaches. J Dent Res 2011; 90(5): 561-572.
85. Scully C, Carrozzo M. Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 2008; 46(1): 15-21.
86. Dan H, Liu W, Zhou Y et al. Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation 2010; 33(2): 76-81.
87. Rhodus NL, Cheng B, Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm 2007; 2007: 19854.
88. Bai J, Lin M, Zeng X et al. Association of polymorphisms in the human IFN-c and IL-4 gene with oral lichen planus: a study in an ethnic Chinese cohort. J Interferon Cytokine Res 2008; 28(6): 351-358.
89. Zhang Y, Lin M, Zhang S et al. NF-kB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine 2008; 41(2): 144-149.
90. Zhang Y, Liu W, Zhang S et al. Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation 2012; 35(2): 399-404.
91. Taghavi Zenouz A, Pouralibaba F, Babaloo Z et al. Evaluation of serum TNF-a and TGFb in patients with oral lichen planus. J Dent Res Dent Clin Dent Prospects 2012; 6(4): 143-147.
92. Bai J, Jiang L, LinMet al. Association of polymorphisms in the tumor necrosis factor-a and interleukin-10 genes with oral lichen planus: a study in a Chinese cohort with Han ethnicity. J Interferon Cytokine Res 2009; 29(7): 381-388.
93. NovakN, GrosE, Bieber T et al. Human skin and oralmucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses. Clin Exp Immunol 2010; 161(1): 28-33.
94. Mascarell L, Saint-Lu N, Moussu H et al. Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice. Mucosal Immunol 2011; 4(6): 638-647.
95. Chen W. IDO: more than an enzyme. Nat Immunol 2011; 12(9): 809-811.
96. Bohle B, Kinaciyan T, Gerstmayr M et al. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120(3): 707-713.
97. Yoshitomi T, Nakagami Y, Hirahara K et al. Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice. J Pept Sci 2007; 13(8): 499-503.
98. Chen Q, Xia J, LinMet al. Serum interleukin-6 in patients with burning mouth syndrome and relationship with depression and perceived pain. Mediators Inflamm 2007; 2007: 45327.